IP Library Granted Patent US 8,658,424
Granted Patent B2
US 8,658,424 · App. 13/536,214 · Granted Feb 25, 2014

Myelinating oligodendrocyte precursor populations

Inventors: Su-Chun Zhang (Middleton, WI); Baoyang Hu (Madison, WI); Zhong-Wei Du (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,658,424
App. No.
13/536,214
Granted
Feb 25, 2014
Kind
B2
Abstract

A method of differentiating embryonic stem cells into oligodendroglial precursor cells and oligodendroglial cells by culturing a population of cells comprising a majority of cells that are characterized by a neural tube-like rosette morphology and are Pax6+/Sox1+ into a population of cells that are PDGFRα+.

Claims (10)

1. An enriched in vitro population of human Olig2 + /PDGFR-alpha + oligodendroglial precursor cells, wherein the population is at least 80% pure, is derived from isolated human pluripotent cells, and is enriched for Olig2 + /PDGFR-alpha + oligodendroglial precursor cells capable of differentiating into myelinogenic oligodendrocytes relative to a naturally occurring population of oligodendroglial precursor cells.

2. The enriched in vitro population of claim 1 , wherein the population is derived from isolated human neural stem cells derived from a neural tube-like rosette culture.

3. The enriched in vitro population of claim 2 , wherein the isolated human neural stem cells derived from a neural tube-like rosette culture are Pax6 + /Sox1 + .

4. The enriched in vitro population of claim 1 , wherein the population is at least 90% pure.

5. The enriched in vitro population of claim 1 , wherein the population is at least 95% pure.

6. An enriched in vitro population of human Olig2 + /Nkx2.2 + /Sox10 + /PDGFR-alpha + oligodendroglial precursor cells, wherein the population is at least 80% pure, is derived from isolated human pluripotent cells, and is enriched for human Olig2 + /Nkx2.2 + /Sox10 + /PDGFR-alpha + oligodendroglial precursor cells capable of differentiating into myelinogenic oligodendrocytes relative to a naturally occurring population of oligodendroglial precursor cells.

7. The enriched in vitro population of claim 6 , wherein the population is derived from isolated human neural stem cells derived from a neural tube-like rosette culture.

8. The enriched in vitro population of claim 7 , wherein the isolated human neural stem cells derived from a neural tube-like rosette culture are Pax6 + /Sox1 + .

9. The enriched in vitro population of claim 6 , wherein the population is at least 90% pure.

10. The enriched in vitro population of claim 6 , wherein the population is at least 95% pure.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jul 10, 2012
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028521/0094 →
Continuity (3)
Continuation 12338749 · Dec 18, 2008
Provisional Application 61015407 · Dec 20, 2007
Related Publication 20130011917A1 · Jan 10, 2013